After Donald Trump’s praise for his treatment for the coronavirus, the manufacturer asks for an emergency authorization

Slovakia is launching massive corona testing: the entire population is set to be tested

Slovakia will start massive mass testing today, Saturday, in which the entire population of the country will be tested for the coronavirus. Slovakia...

Death toll in the earthquake in Turkey and Greece rises to 24, more than 800 injured

The death toll from the earthquake in the Aegean Sea has risen to 26. In western Turkey, at least 24 people were killed and...

Cuba without options to receive remittances after the closure of Wester Union

The financial corporation Fincimex, linked to the Cuban Armed Forces, ruled out the possibility of enabling alternative channels for the sending remittances that...

Trudeau on violence in France: “Freedom of expression has its limits”

Prime Minister of Canada Justin trudeau to take a stand on the violence that has shocked France by speaking out in favor of freedom...

Japan develops COVID-19 antibody test with silkworms

Researchers at Kyushu University in southwestern Japan and a medical equipment manufacturer in the country have developed a antibody test of COVID-19 using...

Pharmaceutical Regeneron applied for permission to make its monoclonal antibody therapy available to the entire population.

The biotechnology company Regeneron, owner of the monoclonal antibody treatment that US President Donald Trump has received during his convalescence from coronavirus, asked the US drug regulator for an emergency authorization so that his therapy is available to the entire population.

Regeneron’s shares opened this Thursday with a rise of 2.4% after the announcement and Trump saying on Wednesday that Regeneron’s antibody cocktail was the main responsible for his improvement after testing positive for Covid-19 and defining it, not as “therapy”, but as “cure”, even though there is no scientific evidence to support that conclusion.

Regeneron asked the Food and Drug Administration (FDA) that the REGN-COV2 antibody, which the president received during his stay at Walter Reed military hospital between Friday and Monday, obtain authorization from the fast track until there is enough data to receive permanent authorization.

The biotechnology company said in a statement that once the authorization is guaranteed, “the (US) government has committed to making doses available to Americans at no cost and will be responsible for their distribution.”

Regeneron indicated that currently has doses for 50,000 patients, but he hopes to have enough available to treat 300,000 patients “in a few months.”

The United States, where more than 211,000 people died from Covid-19, has more than 4 million active cases (infected fewer recovered and deceased) of coronavirus today, according to data compiled by Johns Hopkins University.

Trump received an 8-gram dose of an antibody cocktail from Regeneron shortly after his positive was confirmed and even though its use was not authorized by the FDA.

In a video posted on his social media on Wednesday, the US president said he wants his treatment, which also included five doses of the antiviral Remdesivir (authorized by the FDA) and steroids, to be available to all Americans.

“I got sick, I heard about this medicine (Regeneron). I said, ‘let me take it.’ That was my suggestion and the good work was incredible. I want for you what I had and I’m going to do it for free, you won’t have to pay for it “, assured the president in his message spread by Twitter, while he tries to be healthy in the last stretch of the presidential campaign.

Source: EFE



Related Articles